symbol

Mitsubishi Tanabe Acquires Israeli Pharma Company NeuroDerm For $1.1B

Mitsubishi Tanabe Acquires Israeli Pharma Company NeuroDerm For $1.1B

Japan’s Mitsubishi Tanabe Pharma Corporation (MTPC) is buying Israeli pharmaceutical company NeuroDerm, which is traded on the NASDAQ, for a whopping $1.1 billion (or $39 per share), in one of the largest deals in Israel’s history. This is also the largest ever acquisition of an Israeli healthcare company, as well as one of the largest purchases of an Israeli business by a Japanese company.

Earlier this year, Intel made the largest acquisition when it bought Israeli autonomous car tech company Mobileye for $15.3 billion.

For more information, please click here.